Catalyst Wire Dossier Catalyst Wire Dossier

β-globin Restored Autologous Hematopoietic Stem Cells

· Shenzhen Hemogen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for β-globin Restored Autologous Hematopoietic Stem Cells, covering 2024-11-29 to 2024-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Evaluation of β-globin Restored Autologous Hematopoietic Stem Cells in β-thalassemia Major Patients [EARLY_Phase 1]

See pricing